1st Detect Reports Revenue of $148,000
Reports revenue $148,000 vs. $261,000 last year. "We continue to see positive momentum in our sales pipeline across our global markets year-to-date in fiscal year 2026. Customers in our end markets are increasingly recognizing the value of our mass spectrometry and gas chromatography solutions, which offer real-time operational results and extensive reference libraries that can be tailored to specific end market applications. We believe our library capabilities are of particular interest in the explosives and narcotics trace detection markets, as new narcotics and explosives are being discovered, leading to an urgent need for the ability to expand screening capabilities for both public safety and law enforcement in particular," said Thomas Pickens, III, CEO. "Additionally, we have strengthened our team with the appointment of Scott Bartley as Interim Chief Financial Officer and David Spada as Director of Global Sales in our 1st Detect subsidiary as we move toward sustained revenue growth and global scale."
Trade with 70% Backtested Accuracy
Analyst Views on ASTC
About ASTC
About the author
Astrotech Reports Q2 Financial Results with Strategic Review Initiated
- Financial Performance: Astrotech's Q2 GAAP EPS stands at -$2.34 with revenue of $0.15 million, reflecting a significant 42.3% year-over-year decline, indicating substantial challenges faced during the company's transition phase.
- R&D Expense Trends: Research and development expenses totaled $1.832 million, down 25% from Q2 of fiscal year 2025, highlighting the company's shift from development to marketable products, particularly in the EN-SCAN handheld GC and 1stDetect Tracer 1000 lines.
- Market Deployment Update: As of December 31, 2025, the TRACER 1000 trace detection system has been deployed in approximately 35 locations across 16 countries in the U.S., Europe, and Asia, showcasing the company's efforts to expand its global footprint.
- Strategic Review Initiation: Astrotech has initiated a review of strategic alternatives, including a potential sale, indicating the company's pursuit of restructuring or divestiture to enhance its financial health and market performance.
ASTROTECH REPORTS Q2 OPERATING EXPENSES OF USD 3.909 MILLION
Operating Expenses: A report indicates that the operating expenses for the company ASTROTECH in Q2 amounted to USD 3.909 million.
Financial Overview: The financial performance reflects the company's ongoing investments and operational costs during the second quarter.
ASTROTECH REPORTS Q2 NET LOSS OF USD 3.927 MILLION
Company Overview: AstroTech reported a net income of USD 3.927 million for the second quarter.
Financial Performance: The financial results indicate a positive trend in the company's profitability during this period.
ASTROTECH Reports Q2 EPS of -2.34 USD
Overview of ASTROTECH: ASTROTECH is a company focused on providing innovative solutions in the aerospace and defense sectors, emphasizing technology development and operational efficiency.
Q2 EPS Results: The company reported its earnings per share (EPS) for the second quarter, showcasing financial performance and growth metrics that align with its strategic goals.
Future Projections: ASTROTECH outlined its future projections, indicating expected growth in revenue and market expansion, driven by new contracts and technological advancements.
Market Positioning: The company is positioning itself competitively within the aerospace industry, leveraging partnerships and collaborations to enhance its service offerings and market reach.
ASTROTECH REPORTS Q2 REVENUE OF $148,000
- Company Overview: ASTRATECH reported a revenue of USD 148,000 for the second quarter.
- Financial Performance: The revenue figure indicates the company's financial performance during this period.
Astrotech Subsidiary Appoints Sales Director to Accelerate TRACER 1000 Global Deployment
- Executive Appointment: Astrotech's subsidiary 1st Detect has appointed David Spada as Director of Global Sales, leveraging his over ten years of specialized experience to enhance the company's commercial leadership in international security markets and accelerate the global deployment of the TRACER 1000.
- Technological Advantage: The TRACER 1000 utilizes mass spectrometry to deliver laboratory-grade trace detection, helping security teams reduce false alarms and strengthen screening checkpoints, addressing the urgent modernization needs of global security agencies.
- Market Outlook: Spada noted that the TRACER 1000 features disruptive technology, which is expected to usher in a new era of high-performance mass spectrometry-based trace detection, thereby increasing shareholder value and enhancing the company's competitive position in the market.
- Strategic Goals: Astrotech CEO Thomas B. Pickens III emphasized that the mature technology of the TRACER 1000 will set a new standard in security screening, reflecting the company's strong commitment to advancing security detection technologies.
Astrotech Reports Q2 Financial Results with Strategic Review Initiated
- Financial Performance: Astrotech's Q2 GAAP EPS stands at -$2.34 with revenue of $0.15 million, reflecting a significant 42.3% year-over-year decline, indicating substantial challenges faced during the company's transition phase.
- R&D Expense Trends: Research and development expenses totaled $1.832 million, down 25% from Q2 of fiscal year 2025, highlighting the company's shift from development to marketable products, particularly in the EN-SCAN handheld GC and 1stDetect Tracer 1000 lines.
- Market Deployment Update: As of December 31, 2025, the TRACER 1000 trace detection system has been deployed in approximately 35 locations across 16 countries in the U.S., Europe, and Asia, showcasing the company's efforts to expand its global footprint.
- Strategic Review Initiation: Astrotech has initiated a review of strategic alternatives, including a potential sale, indicating the company's pursuit of restructuring or divestiture to enhance its financial health and market performance.
ASTROTECH REPORTS Q2 OPERATING EXPENSES OF USD 3.909 MILLION
Operating Expenses: A report indicates that the operating expenses for the company ASTROTECH in Q2 amounted to USD 3.909 million.
Financial Overview: The financial performance reflects the company's ongoing investments and operational costs during the second quarter.
ASTROTECH REPORTS Q2 NET LOSS OF USD 3.927 MILLION
Company Overview: AstroTech reported a net income of USD 3.927 million for the second quarter.
Financial Performance: The financial results indicate a positive trend in the company's profitability during this period.
ASTROTECH Reports Q2 EPS of -2.34 USD
Overview of ASTROTECH: ASTROTECH is a company focused on providing innovative solutions in the aerospace and defense sectors, emphasizing technology development and operational efficiency.
Q2 EPS Results: The company reported its earnings per share (EPS) for the second quarter, showcasing financial performance and growth metrics that align with its strategic goals.
Future Projections: ASTROTECH outlined its future projections, indicating expected growth in revenue and market expansion, driven by new contracts and technological advancements.
Market Positioning: The company is positioning itself competitively within the aerospace industry, leveraging partnerships and collaborations to enhance its service offerings and market reach.
ASTROTECH REPORTS Q2 REVENUE OF $148,000
- Company Overview: ASTRATECH reported a revenue of USD 148,000 for the second quarter.
- Financial Performance: The revenue figure indicates the company's financial performance during this period.
Astrotech Subsidiary Appoints Sales Director to Accelerate TRACER 1000 Global Deployment
- Executive Appointment: Astrotech's subsidiary 1st Detect has appointed David Spada as Director of Global Sales, leveraging his over ten years of specialized experience to enhance the company's commercial leadership in international security markets and accelerate the global deployment of the TRACER 1000.
- Technological Advantage: The TRACER 1000 utilizes mass spectrometry to deliver laboratory-grade trace detection, helping security teams reduce false alarms and strengthen screening checkpoints, addressing the urgent modernization needs of global security agencies.
- Market Outlook: Spada noted that the TRACER 1000 features disruptive technology, which is expected to usher in a new era of high-performance mass spectrometry-based trace detection, thereby increasing shareholder value and enhancing the company's competitive position in the market.
- Strategic Goals: Astrotech CEO Thomas B. Pickens III emphasized that the mature technology of the TRACER 1000 will set a new standard in security screening, reflecting the company's strong commitment to advancing security detection technologies.
